[1]
Herrera, A.L.G. et al. 2019. Prolonged Survival on PARP Inhibitor Therapy In a Patient With Stage IV Non-small Cell Lung Cancer: A Case Report. Archives of Clinical and Medical Case Reports. 3, 2 (Mar. 2019), 59–61.